Clinical perspective - Cough

An unmet need

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Cough is among the most common complaints for which individuals worldwide seek medical attention. The vast majority of cases of acute cough (<3 weeks duration) are due to acute viral upper respiratory tract infection (URI) (common cold). Fortunately, acute cough is typically transient and self-limited. However, should severe and/or persistent acute cough require pharmacological treatment, satisfactory therapeutic options are scarce. Narcotic antitussives are limited by unacceptable side effects at therapeutic doses, and most over-the-counter (OTC) remedies are not supported by adequate clinical trials. The goal in chronic cough (>8 weeks duration) is to meticulously evaluate and treat all potential underlying etiologies. Despite thorough investigation, a significant minority of patients will suffer refractory, unexplained cough. For this challenging population, safe, effective, non-narcotic antitussive therapies are desperately needed.

Original languageEnglish (US)
Article number1400
Pages (from-to)24-28
Number of pages5
JournalCurrent Opinion in Pharmacology
Volume22
DOIs
StatePublished - 2015

Fingerprint

Cough
Antitussive Agents
Population
Therapeutics

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

Clinical perspective - Cough : An unmet need. / Dicpinigaitis, Peter Vytautas.

In: Current Opinion in Pharmacology, Vol. 22, 1400, 2015, p. 24-28.

Research output: Contribution to journalArticle

@article{c69119d9426a4d25a9d614e8f53a5a88,
title = "Clinical perspective - Cough: An unmet need",
abstract = "Cough is among the most common complaints for which individuals worldwide seek medical attention. The vast majority of cases of acute cough (<3 weeks duration) are due to acute viral upper respiratory tract infection (URI) (common cold). Fortunately, acute cough is typically transient and self-limited. However, should severe and/or persistent acute cough require pharmacological treatment, satisfactory therapeutic options are scarce. Narcotic antitussives are limited by unacceptable side effects at therapeutic doses, and most over-the-counter (OTC) remedies are not supported by adequate clinical trials. The goal in chronic cough (>8 weeks duration) is to meticulously evaluate and treat all potential underlying etiologies. Despite thorough investigation, a significant minority of patients will suffer refractory, unexplained cough. For this challenging population, safe, effective, non-narcotic antitussive therapies are desperately needed.",
author = "Dicpinigaitis, {Peter Vytautas}",
year = "2015",
doi = "10.1016/j.coph.2015.03.001",
language = "English (US)",
volume = "22",
pages = "24--28",
journal = "Current Opinion in Pharmacology",
issn = "1471-4892",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Clinical perspective - Cough

T2 - An unmet need

AU - Dicpinigaitis, Peter Vytautas

PY - 2015

Y1 - 2015

N2 - Cough is among the most common complaints for which individuals worldwide seek medical attention. The vast majority of cases of acute cough (<3 weeks duration) are due to acute viral upper respiratory tract infection (URI) (common cold). Fortunately, acute cough is typically transient and self-limited. However, should severe and/or persistent acute cough require pharmacological treatment, satisfactory therapeutic options are scarce. Narcotic antitussives are limited by unacceptable side effects at therapeutic doses, and most over-the-counter (OTC) remedies are not supported by adequate clinical trials. The goal in chronic cough (>8 weeks duration) is to meticulously evaluate and treat all potential underlying etiologies. Despite thorough investigation, a significant minority of patients will suffer refractory, unexplained cough. For this challenging population, safe, effective, non-narcotic antitussive therapies are desperately needed.

AB - Cough is among the most common complaints for which individuals worldwide seek medical attention. The vast majority of cases of acute cough (<3 weeks duration) are due to acute viral upper respiratory tract infection (URI) (common cold). Fortunately, acute cough is typically transient and self-limited. However, should severe and/or persistent acute cough require pharmacological treatment, satisfactory therapeutic options are scarce. Narcotic antitussives are limited by unacceptable side effects at therapeutic doses, and most over-the-counter (OTC) remedies are not supported by adequate clinical trials. The goal in chronic cough (>8 weeks duration) is to meticulously evaluate and treat all potential underlying etiologies. Despite thorough investigation, a significant minority of patients will suffer refractory, unexplained cough. For this challenging population, safe, effective, non-narcotic antitussive therapies are desperately needed.

UR - http://www.scopus.com/inward/record.url?scp=84924754751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924754751&partnerID=8YFLogxK

U2 - 10.1016/j.coph.2015.03.001

DO - 10.1016/j.coph.2015.03.001

M3 - Article

VL - 22

SP - 24

EP - 28

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

SN - 1471-4892

M1 - 1400

ER -